Company: IPAR
Filing Date: 2025-07-14
Form Type: PRE 14A
Source: 0001753926-25-001139
Chunk: 43

Company: INTERPARFUMS INC
Filing Date: 2025-07-14
Form: PRE 14A
Chunk 43
---
     |                        | 68,048 |     |       | 127,017 |
| Kappauf                |     |                             | 18,000 |     |        | -0- |     |                       | 49,969 |     |                                        | -0- |     |                                                 | -0- |     |                        |    -0- |     |       |  67,969 |

[Footnotes from table above]

| 1. | Represents gain from exercise of stock options. |

All nonemployee directors receive $6,000 for each board meeting at which they participate in person, and $3,000 for each meeting held by conference telephone. In addition, the annual fee for each member of the Audit Committee is $8,000. We maintain a stock option plan for our nonemployee or independent directors. The purpose of this plan is to assist us in attracting and retaining key directors who are responsible for continuing the growth and success of our company. Under such plan, options to purchase 1,500 shares are granted on the last business day of each year at the fair market value on the date of grant to all nonemployee directors for as long as each is a nonemployee director on such date. Such options vest and become exercisable to purchase shares of Common Stock as follows: 20% one year after the date of grant, and then 20% on each of the second, third, fourth and fifth consecutive years from the date of grant on a cumulative basis, so that each option shall become fully vested and exercisable on the first day of the sixth year from the date of grant. However, if a nonemployee director does not attend certain of the board meetings, then such option grants are reduced according to a schedule. The following table sets forth certain information as of the end of our last fiscal year regarding all equity compensation plans that provide for the award of equity securities or the grant of options, warrants or rights to purchase our equity securities.

| 28 |

Equity Compensation Plan Information

| Plan category                                              |     | Number of     
 securities to 
 be issued     
 upon          
 exercise of   
 outstanding   
 options,      
 warrants and  
 rights        
 (a)           |         |     | Weighted-average  
 exercise price of 
 outstanding       
 options, warrants 
 and rights        
 (b)               |         |     | Number of       
 securities      
 remaining       
 available for   
 future issuance 
 under equity    
 compensation    
 plans           
 (excluding      
 securities      
 reflected in    
 column (a))     
 (